By voice vote, the full Appropriations Committee of the U.S. House of Representatives today restored language to a 2020 spending bill that bars the FDA from considering requests to approve any clinical trial “in which a human embryo is intentionally created or modified to include a heritable genetic modification.”

Quick Read

Administrators at the MD Anderson Cancer Center in Houston, Texas, yesterday tried to reassure alarmed employees that its recent dismissals of faculty members alleged to have broken federal funding rules were not connected to race or ethnicity

Quick Read

The U.S. government’s leading medical research agency is quietly extending and reviving research that relies on human fetal tissue, even as President Donald Trump’s administration ponders the future of the controversial work in a far-reaching review

Quick Read

Jonathan Moreno writes, “Over the past couple of years, I’ve noticed an apparent reluctance among the U.S. government agencies that fund neuroscience to be associated with projects that explicitly describe work on the nature of consciousness…”

Quick Read

The federal government’s new rule requiring hospitals to post prices for their services is intended to allow patients to shop around and compare prices, a step toward price transparency that has generated praise and skepticism

Quick Read

The suit, filed in a Texas district court on Tuesday, makes a new legal argument that relies on Congress’s recent repeal of the individual mandate penalty.

Quick Read

The Uncertain Hour Podcast explores food regulation and the story of Ruth Desmond AKA “Peanut Butter Grandma”. Featuring comments from our Angie Boyce.

Read More

At a Senate Health, Education, Labor and Pensions (HELP) hearing in Washington, D.C. on Tuesday, experts, including our Jeffrey Kahn, explained that the current regulatory framework for gene editing in the US is appropriate and cautioned that an overly strict approach could drive research to other countries

Quick Read